Literature DB >> 16782484

Mild cognitive impairment.

Ronald C Petersen.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16782484     DOI： 10.1016/S0140-6736(06)68881-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer's disease: a meta-analysis.

Authors:  Xue-Fei He; Yi-Ting Liu; Cheng Peng; Fan Zhang; Shi Zhuang; Jin-Song Zhang
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

2.  Correlates of Conversion from Mild Cognitive Impairment to Dementia with Lewy Bodies: Data from the National Alzheimer's Coordinating Center.

Authors:  Sarah Payne; Jane B Shofer; Andrew Shutes-David; Ge Li; Adrienne Jankowski; Pamela Dean; Debby Tsuang
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 3.  Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.

Authors:  Roberto Raschetti; Emiliano Albanese; Nicola Vanacore; Marina Maggini
Journal:  PLoS Med       Date:  2007-11-27       Impact factor: 11.069

4.  Disruptions of the olfactory and default mode networks in Alzheimer's disease.

Authors:  Jiaming Lu; Qing X Yang; Han Zhang; Paul J Eslinger; Xin Zhang; Sichu Wu; Bing Zhang; Bin Zhu; Prasanna R Karunanayaka
Journal:  Brain Behav       Date:  2019-06-04       Impact factor: 2.708

5.  Functional Connectivity between the Resting-State Olfactory Network and the Hippocampus in Alzheimer's Disease.

Authors:  Jiaming Lu; Nicole Testa; Rebecca Jordan; Rommy Elyan; Sangam Kanekar; Jianli Wang; Paul Eslinger; Qing X Yang; Bing Zhang; Prasanna R Karunanayaka
Journal:  Brain Sci       Date:  2019-11-25

6.  Visual Abnormalities Associate With Hippocampus in Mild Cognitive Impairment and Early Alzheimer's Disease.

Authors:  Aonan Zhao; Fang Fang; Binyin Li; Yan Chen; Yinghui Qiu; Yanli Wu; Wei Xu; Yulei Deng
Journal:  Front Aging Neurosci       Date:  2021-01-22       Impact factor: 5.750

7.  Abnormal regional homogeneity in right caudate as a potential neuroimaging biomarker for mild cognitive impairment: A resting-state fMRI study and support vector machine analysis.

Authors:  Yujun Gao; Xinfu Zhao; JiChao Huang; Sanwang Wang; Xuan Chen; Mingzhe Li; Fengjiao Sun; Gaohua Wang; Yi Zhong
Journal:  Front Aging Neurosci       Date:  2022-09-01       Impact factor: 5.702

8.  Reshaping the path of mild cognitive impairment by refining exercise prescription: a study protocol of a randomized controlled trial to understand the "what," "for whom," and "how" of exercise to promote cognitive function.

Authors:  Cindy K Barha; Ryan S Falck; John R Best; Lindsay S Nagamatsu; Ging-Yuek Robin Hsiung; A William Sheel; Chun Liang Hsu; Arthur F Kramer; Michelle W Voss; Kirk I Erickson; Jennifer C Davis; J Kevin Shoemaker; Lara Boyd; Rachel A Crockett; Lisanne Ten Brinke; Louis Bherer; Joel Singer; Liisa A M Galea; Claudia Jacova; Alexis Bullock; Sofia Grant; Teresa Liu-Ambrose
Journal:  Trials       Date:  2022-09-09       Impact factor: 2.728

9.  The modulation effect of non-invasive brain stimulation on cognitive function in patients with mild cognitive impairment: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ying Xu; Zhijie Qiu; Jingfang Zhu; Jiao Liu; Jingsong Wu; Jing Tao; Lidian Chen
Journal:  BMC Neurosci       Date:  2019-01-03       Impact factor: 3.288

10.  Mild cognitive impairment: the Manchester consensus.

Authors:  Ross A Dunne; Dag Aarsland; John T O'Brien; Clive Ballard; Sube Banerjee; Nick C Fox; Jeremy D Isaacs; Benjamin R Underwood; Richard J Perry; Dennis Chan; Tom Dening; Alan J Thomas; Jeffrey Schryer; Anne-Marie Jones; Alison R Evans; Charles Alessi; Elizabeth J Coulthard; James Pickett; Peter Elton; Roy W Jones; Susan Mitchell; Nigel Hooper; Chris Kalafatis; Jill G C Rasmussen; Helen Martin; Jonathan M Schott; Alistair Burns
Journal:  Age Ageing       Date:  2021-01-08       Impact factor: 12.782
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.